Skip to main content
BEAM logo

BEAM · Beam Therapeutics Inc. · Executive Compensation

Track BEAM — free
$20.90 -0.04 (-0.19%) At close · Nov 20 Play latest call Q4 2025 earnings call transcript
Market Cap
$2.16B
Shares
103.50M
Volume · Nov 20 3.89M Avg daily vol (3M) 2.05M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
John Evans $5,818,525
Giuseppe Ciaramella $3,160,279
Amy Simon $2,802,044
Christine Bellon $1,967,177
Sravan K. Emany $1,296,528
Fiscal 2024
Executive Total
John Evans $6,409,631
Sravan K. Emany $4,818,306
Giuseppe Ciaramella $3,378,647
Terry-Ann Burrell $2,768,161
Amy Simon $2,615,681
Christine Bellon $2,581,460
Fiscal 2023
Executive Total
John Evans $6,280,099
Giuseppe Ciaramella $2,785,194
Terry-Ann Burrell $2,557,844
Amy Simon $2,545,219
Christine Bellon $2,281,013
Fiscal 2022
Executive Total
John Evans $9,496,745
Giuseppe Ciaramella $3,169,575
Terry-Ann Burrell $2,947,530
Fiscal 2021
Executive Total
John Evans $13,911,975
Giuseppe Ciaramella $5,535,622
Terry-Ann Burrell $3,938,904
Fiscal 2020
Executive Total
Giuseppe Ciaramella $6,852,786
John Evans $906,768
Terry-Ann Burrell $683,752
Fiscal 2019
Executive Total
Terry-Ann Burrell $4,302,723
John Evans $2,209,800
Giuseppe Ciaramella $1,588,450

Executive changes

Person Change Filed
Carole Ho
“Dr. Ho’s decision to resign did not result from any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.”
Resigned 2026-02-05
Sravan K. Emany Appointed 2024-12-06
Chirfi Guindo Appointed 2024-12-04
Terry-Ann Burrell Resigned 2024-07-15
Christi Shaw Appointed 2023-12-14
John Maraganore Appointed 2021-11-08
Robert Nelsen
“Mr. Nelsen’s decision to resign did not result from any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.”
Resigned 2021-05-24
Stephen Knight, M.D.
“Dr. Knight’s decision to resign did not result from any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.”
Resigned 2021-04-23

Leadership

Key facts CIK 1745999 CUSIP 07373V105 13F (30d) 270 filings 247 filers Visit website Investor relations